Article
Isocitrate Dehydrogenase Mutation Assessment in Human Glioma Using Desorption Electrospray Ionization-Multiple Reaction Monitoring.
Analytical chemistry - 4 Aug 2026
Shahi Mahdiyeh, Garcia Diogo Moniz, Quiñones-Hinojosa Alfredo, Cooks R Graham
Abstract excerpt
The mutation status of isocitrate dehydrogenase (IDH) in glioma patients has diagnostic and prognostic significance but is available only after surgery. Rapid and sensitive intraoperative molecular diagnosis is essential for distinguishing tumor from infiltrative and from normal brain tissue to maximize safe resection. IDH-mutant (mut)tumors produce high concentrations of 2-hydroxyglutarate (2HG), which serves as...
Topics
Join the communities discussing this publication.
